Luteinizing hormone supplementation and cumulative live birth rate in assisted reproductive technology cycles among women of advanced reproductive age
Leizhen Xia, Wenting Xia, Lifeng Tian, Jialyu Huang, Houyang Chen, Li Cai, Leixiang Xia, Yan Zhao, Wei Gao · 2026
Read Luteinizing hormone supplementation and cumulative live birth rate in assisted reproductive technology cycles among women of advanced reproductive age by Leizhen Xia, Wenting Xia, Lifeng Tian, Jialyu Huang, Houyang Chen, Li Cai, Leixiang Xia, Yan Zhao, Wei Gao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13318672.txt.
Description
Leizhen Xia and co-authors present a 2026 retrospective cohort study of fertility treatment. They ask whether adding luteinizing hormone helps women of advanced reproductive age. The study covers assisted reproduction cycles from 2015 to 2024. It includes 2,316 women in three stimulation groups.
One group used follicle stimulating hormone alone. Others added recombinant LH or human menopausal gonadotropin. Matching balanced the groups before comparison. The combined LH group reached a cumulative live birth rate of 61.31 percent. The hormone-alone group reached 51.48 percent in the matched comparison. Adjusted models also favoured added recombinant LH over both alternatives. Fresh transfer results did not differ, and the authors warn against causal claims.
Catalog record
| CREATOR | Leizhen Xia, Wenting Xia, Lifeng Tian, Jialyu Huang, Houyang Chen, Li Cai, Leixiang Xia, Yan Zhao, Wei Gao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52121 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |